Cargando…

Aggressive B-Cell Lymphomas

Detalles Bibliográficos
Autores principales:	Naresh, Kikkeri N., Magrath, Ian, Raphael, Martine, Leoncini, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352139/ https://www.ncbi.nlm.nih.gov/pubmed/22611401 http://dx.doi.org/10.1155/2012/604603

Ejemplares similares

Proposal of ‘reactive‐lymphocyte/histiocyte rich large B‐cell lymphoma’ as an alternate term for ‘nodular lymphocyte predominant Hodgkin lymphoma’ that would also address its overlap with T‐cell/histiocyte rich large B‐cell lymphoma
por: Naresh, Kikkeri N.
Publicado: (2022)

Epigenetics, c-Myc and Aggressive B-cell Lymphomas
por: Zhang, Yizhuo, et al.
Publicado: (2012)

MEF2B is the ideal immunohistochemical marker to highlight neoplastic LP cells in nodular lymphocyte‐predominant Hodgkin lymphoma
por: Torabi, Alireza, et al.
Publicado: (2023)

P048: Predictors of risk of relapse in classic Hodgkin lymphoma by flow cytometry
por: Fromm, Jonathan, et al.
Publicado: (2022)

A 70% cut-off for MYC protein expression in diffuse large B-cell lymphoma identifies a high-risk group of patients
por: Ziepert, Marita, et al.
Publicado: (2020)

The Alteration of Lipid Metabolism in Burkitt Lymphoma Identifies a Novel Marker: Adipophilin
por: Ambrosio, Maria R., et al.
Publicado: (2012)

Novel Therapies for Aggressive B-Cell Lymphoma
por: Foon, Kenneth A., et al.
Publicado: (2012)

Molecular classification of aggressive B-cell lymphoma
por: Bojarczuk, Kamil, et al.
Publicado: (2019)

Epstein–Barr Virus-Induced Metabolic Rearrangements in Human B-Cell Lymphomas
por: Piccaluga, Pier P., et al.
Publicado: (2018)

Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma: An Underrecognized Aggressive Lymphoma
por: Morgan, Elizabeth A., et al.
Publicado: (2012)

Microenvironment-Centred Dynamics in Aggressive B-Cell Lymphomas
por: Cacciatore, Matilde, et al.
Publicado: (2012)

Biological Approaches to Aggressive Cutaneous B-Cell Lymphomas
por: Tadiotto Cicogna, Giulia, et al.
Publicado: (2019)

The International Prognostic Index in aggressive B-cell lymphoma
por: Maurer, Matthew J.
Publicado: (2023)

Renal Lymphoma: Primary or First Manifestation of Aggressive Pediatric B-cell Lymphoma
por: Coca, Pragnya, et al.
Publicado: (2017)

Epstein–Barr virus positivity as a defining pathogenetic feature of Burkitt lymphoma subtypes
por: Leoncini, Lorenzo
Publicado: (2021)

Towards Curative Therapy in Burkitt Lymphoma: The Role of Early African Studies in Demonstrating the Value of Combination Therapy and CNS Prophylaxis
por: Magrath, Ian
Publicado: (2012)

Genetic background and evolution of relapses in aggressive B-cell lymphomas
por: Juskevicius, Darius, et al.
Publicado: (2017)

Aggressive B-cell lymphoma subtyping: a pathologists viewpoint
por: de Jong, Daphne
Publicado: (2019)

High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease?
por: Pophali, Priyanka A., et al.
Publicado: (2020)

A Patient With Regressed Diffuse Large B-Cell Lymphoma and Aggressive Follicular Lymphoma
por: Sethi, Ashish K, et al.
Publicado: (2021)

Denis Burkitt and the African lymphoma
por: Magrath, I
Publicado: (2009)

Oncogenic Properties of Apoptotic Tumor Cells in Aggressive B Cell Lymphoma
por: Ford, Catriona A., et al.
Publicado: (2015)

Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop
por: Quintanilla-Martinez, Leticia, et al.
Publicado: (2023)

Epstein–Barr Virus Infection in Cancer
por: Mundo, Lucia, et al.
Publicado: (2023)

Targeting primary mediastinal B-cell lymphoma
por: Wagner, Simon D.
Publicado: (2014)

Extranodal large B-cell type aggressive non-Hodgkin's lymphoma
por: Batra, Ranmeet, et al.
Publicado: (2014)

Response and resistance to CDK12 inhibition in aggressive B-cell lymphomas
por: Gao, Jing, et al.
Publicado: (2021)

PB2161: CHARACTERISTICS OF AGGRESSIVE B-CELL LYMPHOMAS WITH MYC REARRANGEMENT
por: Ortuzar Pasalodos, A., et al.
Publicado: (2022)

Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma
por: Kwon, Mi, et al.
Publicado: (2022)

Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma
por: Eertink, Jakoba J., et al.
Publicado: (2022)

Rituximab retherapy in patients with relapsed aggressive B cell and mantle cell lymphoma
por: Borgerding, Andrea, et al.
Publicado: (2009)

Stem cell characteristics promote aggressiveness of diffuse large B-cell lymphoma
por: Chang, Kung-Chao, et al.
Publicado: (2020)

Impact of MYC on Anti-Tumor Immune Responses in Aggressive B Cell Non-Hodgkin Lymphomas: Consequences for Cancer Immunotherapy
por: de Jonge, A. Vera, et al.
Publicado: (2020)

Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphoma
por: Steiner, Raphael E., et al.
Publicado: (2021)

Regulation of B-Cell Receptor Signaling and Its Therapeutic Relevance in Aggressive B-Cell Lymphomas
por: Profitós-Pelejà, Núria, et al.
Publicado: (2022)

Intensified therapy in diffuse large B-cell lymphoma
por: Novo, Mattia, et al.
Publicado: (2017)

In this issue: Emerging and provisional B and T cell lymphoma entities
por: Quintanilla-Martinez, Leticia
Publicado: (2023)

Primary Hepatosplenic Large B-Cell Lymphoma: A Rare Aggressive Tumor
por: Morales-Polanco, M.R., et al.
Publicado: (2008)

Bone Marrow Involvement by Aggressive B Cell Lymphoma Undetected by Aspirate Immunophenotyping
por: Moshref Razavi, Habib
Publicado: (2021)

Oncogenic HSP90 Facilitates Metabolic Alterations in Aggressive B-cell Lymphomas
por: Calvo-Vidal, M. Nieves, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i0mjn3p4matugfu0hulnftj3js